Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

The Pennant Group, Inc. - Common Stock (NQ:PNTG)

40.82 +0.67 (+1.67%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about The Pennant Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Cash-Producing Stocks We Steer Clear Of
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
2 Healthcare Stocks to Target This Week and 1 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
1 Growth Stock with All-Star Potential and 2 We Find Risky
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr... 
Via StockStory
News headline image
Senior Health, Home Health & Hospice Stocks Q2 Results: Benchmarking The Pennant Group (NASDAQ:PNTG)
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how senior health, home he... 
Via StockStory
Topics Economy
Pennant Group (NASDAQ:PNTG) Q2 Earnings Beat Revenue Estimates, Shares Dip in After-Market ↗
Via Chartmill
Topics Earnings
PENNANT GROUP INC/THE (NASDAQ:PNTG) Shows Strong Technical and High Growth Momentum Setup ↗
Via Chartmill
Pennant Group (NASDAQ:PNTG) Shows Strong Trend and Growth Momentum ↗
Via Chartmill
Pennant Group Inc (NASDAQ:PNTG) Posts Mixed Q1 Results with EPS Beat and Slim Revenue Miss ↗
Via Chartmill
News headline image
3 Reasons to Avoid PNTG and 1 Stock to Buy Instead
The Pennant Group trades at $37.10 and has moved in lockstep with the market. Its shares have returned 9.7% over the last six months while the S&P 500 has ga... 
Via StockStory
Topics Bankruptcy Stocks Supply Chain
News headline image
Amid Legal Risks, This Company Is Still Rated a Buy ↗
PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved. 
Via MarketBeat
Topics Fraud Initial Public Offering Lawsuit
News headline image
3 Profitable Stocks We’re Skeptical Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
The Pennant Group Q2 Earnings Call Highlights ↗
The Pennant Group (NASDAQ:PNTG) reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company... 
Via MarketBeat
Topics Earnings
News headline image
3 Russell 2000 Stocks We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full-Year Outlook Slightly Exceeds Expectations
Senior living provider The Pennant Group (NASDAQ:PNTG) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 37.3% year on year to $298 million... 
Via StockStory
News headline image
What To Expect From The Pennant Group’s (PNTG) Q2 Earnings
Senior living provider The Pennant Group (NASDAQ:PNTG) will be reporting earnings this Wednesday after market hours. Here’s what to expect. The Pennant Group... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
3 Reasons to Sell PNTG and 1 Stock to Buy Instead
The past six months have been a windfall for The Pennant Group’s shareholders. The company’s stock price has jumped 42.3%, hitting $41.70 per share. This was... 
Via StockStory
Topics Supply Chain
News headline image
What This Pennant Group Insider Sale Means as Home Health Revenue Surged 43% ↗
Guerisoli exercised stock options and immediately liquidated the position following a 57% one-year rally, while retaining ~104,000 shares worth $4.1 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Momentum Stock with Competitive Advantages and 2 We Turn Down
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
Q1 Earnings Roundup: The Pennant Group (NASDAQ:PNTG) And The Rest Of The Senior Health, Home Health & Hospice Segment
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice i... 
Via StockStory
Topics Economy
News headline image
3 Profitable Stocks We Think Twice About
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
3 Healthcare Stocks We Think Twice About
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de... 
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From The Pennant Group’s Q1 Earnings Call
The Pennant Group’s first quarter was met with a positive market response as the company’s non-GAAP profit exceeded expectations, despite revenue coming in s... 
Via StockStory
Topics Earnings Fraud
News headline image
3 Stocks Under $50 with Questionable Fundamentals
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
The Pennant Group Q1 Earnings Call Highlights ↗
The Pennant Group (NASDAQ:PNTG) reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice business, continued senior living margin... 
Via MarketBeat
Topics Earnings
News headline image
Pennant (PNTG) Q1 2026 Earnings Transcript ↗
Pennant (PNTG) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
PNTG Q1 Deep Dive: Integration Progress, Margin Stability, and Southeast Expansion in Focus
Senior living provider The Pennant Group (NASDAQ:PNTG) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 33.3% year on year to $27... 
Via StockStory
News headline image
The Pennant Group (NASDAQ:PNTG) Surprises With Q1 CY2026 Sales
Senior living provider The Pennant Group (NASDAQ:PNTG) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 36.6% year on year... 
Via StockStory
News headline image
3 Profitable Stocks That Fall Short
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
Winners And Losers Of Q4: The Pennant Group (NASDAQ:PNTG) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including The Pennant Group (N... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.